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Abstract
Background: The goals of our study are to determine the most appropriate model for alcohol consumption as an
exposure for burden of disease, to analyze the effect of the chosen alcohol consumption distribution on the
estimation of the alcohol Population- Attributable Fractions (PAFs), and to characterize the chosen alcohol
consumption distribution by exploring if there is a global relationship within the distribution.
Methods: To identify the best model, the Log-Normal, Gamma, and Weibull prevalence distributions were
examined using data from 41 surveys from Gender, Alcohol and Culture: An International Study (GENACIS) and
from the European Comparative Alcohol Study. To assess the effect of these distributions on the estimated alcohol
PAFs, we calculated the alcohol PAF for diabetes, breast cancer, and pancreatitis using the three above-named
distributions and using the more traditional approach based on categories. The relationship between the mean
and the standard deviation from the Gamma distribution was estimated using data from 851 datasets for 66
countries from GENACIS and from the STEPwise approach to Surveillance from the World Health Organization.
Results: The Log-Normal distribution provided a poor fit for the survey data, with Gamma and Weibull
distributions providing better fits. Additionally, our analyses showed that there were no marked differences for the
alcohol PAF estimates based on the Gamma or Weibull distributions compared to PAFs based on categorical
alcohol consumption estimates. The standard deviation of the alcohol distribution was highly dependent on the
mean, with a unit increase in alcohol consumption associated with a unit increase in the mean of 1.258 (95% CI:
1.223 to 1.293) (R2 = 0.9207) for women and 1.171 (95% CI: 1.144 to 1.197) (R2 = 0. 9474) for men.
Conclusions: Although the Gamma distribution and the Weibull distribution provided similar results, the Gamma
distribution is recommended to model alcohol consumption from population surveys due to its fit, flexibility, and
the ease with which it can be modified. The results showed that a large degree of variance of the standard
deviation of the alcohol consumption Gamma distribution was explained by the mean alcohol consumption,
allowing for alcohol consumption to be modeled through a Gamma distribution using only average consumption.
Keywords: Alcohol consumption, Empirical distribution, Gamma distribution, Log-Normal distribution, Weibull dis-
tribution, Population-Attributable Fraction, Exposure distribution, Up-estimation, Per capita consumption, Mean,
Standard deviation
Introduction
Alcohol consumption is a component cause [1] for over
200 International Classification of Diseases (ICD-10)
three-digit codes [2,3]. In other words, a fraction, usually
called the Population-Attributable Fraction (PAF) of the
incidence of these diseases, would disappear if exposure
to one of the causal components was eliminated [4-7]
(in the case of alcohol, under the counterfactual sce-
nario of every person being a lifetime abstainer). The
proportion of the diseases caused by alcohol consump-
tion in a component cause model for a population is
determined by both the patterns and volume of alcohol
consumption and by the relative risks associated with
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each exposure level [3,8]. For most major diseases where
alcohol plays a role (for example, alcohol-attributable
cancers, pancreatitis, and cirrhosis of the liver), the aver-
age volume of alcohol consumption alone was found to
be an adequate predictor of the risk [3,8-10]; however,
some diseases and injuries (for example, ischemic heart
disease, unintentional injuries, and intentional injuries)
were found to be also dependent on drinking patterns
[11-14].
The calculation of an alcohol PAF involves a three-
stage process: 1) estimation of an exposure distribution
of alcohol, 2) establishment of the relative risk function,
and 3) the solving of the equation for the PAF [15].
Since the distribution of alcohol consumption on an
international level has not been agreed upon, the com-
mon approach is to estimate the PAF using categorical
measurements rather than modeling it in a more mathe-
matically appropriate continuous manner [16,17]. The
mathematical expression is as follows:(Formula 1)
PAF =
k∑
i=1
Pi(RRi − 1)
k∑
i=1
Pi(RRi − 1) + 1
where i is the exposure category with baseline expo-
sure or no exposure, i = 0, RRi is the relative risk at
exposure level i compared to no consumption, and Pi is
the prevalence of the jth category of exposure.
When a continuous distribution for the volume of
alcohol consumption is used, this calculation can be
represented by the following formula:(Formula 2)
PAF(x) =
PaRRa + PexRRex +
150∫
0
P(x)RR(x)dx - 1
PaRRa + PexRRex +
150∫
0
P(x)RR(x)dx
where Pa is the prevalence of lifetime abstainers, RRa
is the relative risk of lifetime abstainers, Pex is the preva-
lence of former drinkers, RRex is the relative risk of for-
mer drinkers, x is the average volume of alcohol
consumption per day, P(x) is the prevalence of alcohol
consumption, and RR(x) is the relative risk of drinkers
[15]. Although this is the most accurate way to calculate
a PAF, it requires that the distribution of alcohol con-
sumption be known. Previous attempts at modeling
alcohol consumption using a Log-Normal distribution
have been criticized for various reasons [18,19]; how-
ever, the Log-Normal distribution has provided adequate
approximations for most applications [20,21]. Recently,
more adaptable distributions such as the Gamma distri-
bution have been favored over the Log-Normal distribu-
tion [15,22], and it has been suggested that a mixing of
distributions is needed to separately model the fre-
quency of drinking and the quantity of alcohol con-
sumed [23].
There are two main instruments to monitor alcohol
exposure currently used by countries and international
organizations: 1) general population surveys and 2) esti-
mates of per capita consumption, where per capita con-
sumption is an aggregate measure of recorded,
unrecorded, and tourist per capita consumption of alco-
hol (derived from sales, production, and other economic
statistics) [9,24,25]. These instruments, however, have
limitations [26].
There are no available surveys for many countries, and
in some cases where they do exist they do not allow for
the accurate estimation of the volume of consumption,
as these surveys only ask about the absence or presence
of drinking [27]. Existing surveys often considerably
underestimate real consumption levels [28-30] by typi-
cally covering only 30% to 60% of alcohol sales [26]. As
a result, per capita consumption figures are considered
to be a best estimate of overall volume of consumption
in a country [31]; however, per capita consumption does
not provide any disaggregated statistic and, thus, does
not provide age- and gender-specific consumption esti-
mates. Since in some instances the risk relationship
between alcohol consumption and disease-specific mor-
tality is dependent on gender as well as on age, alcohol
exposure by gender and age is required to estimate the
PAF and to calculate the alcohol-attributable burden of
disease in a population [3].
The problems noted above with respect to surveys
lead to an underestimated burden of disease attributable
to alcohol consumption when PAFs are calculated from
population data without adjustment. As a consequence,
methods have been developed to triangulate both aver-
age alcohol consumption derived from population sur-
veys and from per capita consumption information
[15,26]. However, current PAF calculation methods are
based on categorical estimates of consumption with
alcohol consumption being corrected by multiplying the
two top alcohol consumption categories by the inverse
of the estimated undercoverage (per capita consump-
tion/the estimated per capita consumption from the sur-
vey) [17]. For most categories of disease where there is
an association with volume of alcohol consumption, the
dose-response relationship is nonlinear and, thus, distri-
bution estimates of alcohol consumption by age and
gender are required for accurate estimates of alcohol
PAFs [3].
Given the recent recognition of the need to strengthen
and disseminate information about alcohol as outlined
in the World Health Organization’s strategy to reduce
harmful consumption of alcohol [32], there is a need to
find an appropriate model for exposure, prevalence, and
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distribution of alcohol consumption that can easily be
modeled to make the fit more compatible with per
capita consumption data and that also has properties
that make it possible to estimate the exposure distribu-
tion for countries that lack survey data except for esti-
mates of prevalence of abstention. Thus, the first aim of
this study is to assess internationally if alcohol consis-
tently follows one of the three well-known right-skewed
distributions, Log-Normal, Gamma, or Weibull, and to
determine if the chosen exposure distribution has a sig-
nificant effect on the estimation of a PAF, using the
PAFs for pancreatitis, diabetes, and breast cancer as
examples. The second aim of this study is to investigate
if a global relationship between parameters exists so that
a distribution of alcohol consumption can be estimated
based on mean alcohol consumption.
Methods
Description of underlying surveys
This study used data from Gender, Alcohol and Culture:
An International Study (GENACIS), from the European
Comparative Alcohol Study (ECAS), and from the
STEPwise approach to Surveillance (STEPS). Survey
data were collected for the average volume of consump-
tion for Argentina, Australia (two surveys from Australia
were used: Australia and Australia1), Austria, Belize,
Brazil, Canada, Costa Rica, Czech Republic, Denmark,
Finland, France, Germany, Hungary, Iceland, India, Ire-
land, Isle of Man, Israel, Italy, Japan, Kazakhstan, Mex-
ico, Netherlands, Nicaragua, Nigeria, Norway, Peru,
Spain, Sri Lanka, Sweden, Switzerland, Uganda, United
Kingdom, Uruguay, and the United States of America
from GENACIS (three surveys from the United States of
America were used: USA1, USA2, and USA3; USA1 was
a 2001 longitudinal study that surveyed women only,
and USA2 and USA3 were 1995-1996 and 2000
National Alcohol Surveys, respectively); for Finland,
France, Germany, Italy, Sweden, and the United King-
dom from ECAS; and for Cameroon, Côte D’ Ivoire,
Dominica, Democratic Republic of the Congo, Eritrea,
Kuwait, Mali, Mozambique, American Samoa, Barbados,
Benin, Botswana, Cape Verde, Republic of the Congo,
Cook Islands, Indonesia, Madagascar, St. Kitts and
Nevis, Swaziland, Zambia, Fiji, Kiribati, Marshall Islands,
Mongolia, Nauru, Solomon Islands, Tokelau, Tonga,
Vanuatu, Micronesia, and Samoa from STEPS. (For
information on sampling methodology and the questions
used in GENACIS surveys see [33-35], ECAS see [30],
and STEPS see [36]). For most of the GENACIS surveys
and for the ECAS surveys alcohol consumption was
measured by a beverage-specific usual quantity-fre-
quency technique (i.e., asking separate questions on
usual frequency of drinking, and then eliciting the usual
quantity per drinking occasion), and in the remaining
GENACIS surveys alcohol consumption was measured
by a global quantity-frequency measure. In the STEPS
surveys alcohol consumption was measured in standard
drinks consumed in the seven days preceding the survey.
All data from surveys were divided by sex and age into
eight age groups; 15-24, 25-34, 35-44, 45-54, 55-64, 65-
74, 75-84, and 85 +.
Methods for fitting the distributions
As alcohol consumption distributions have been shown
to have a unimodal shape, [19,37,38] we evaluated the
fit of the Log-Normal, Gamma, and Weibull distribu-
tions (unimodal distributions commonly used to fit
right-skewed empirical data) to determine the most
appropriate distribution to model alcohol consumption
from national survey data. The Log-Normal, Gamma,
and Weibull probability densities are similar in shape,
but have significantly different tail behaviors. In the
past, alcohol consumption has been more commonly
modeled by the Log-Normal distribution as it is used to
model continuous random quantities that are right-
skewed and is based on the normal distribution, making
it easy to fit, test, and modify [20,21]. Although alcohol
consumption is frequently modeled using the Log-Nor-
mal distribution, empirical distributions often deviate
considerably from the Log-Normal model. In compari-
son, the Gamma and Weibull distributions have a scale
parameter and a shape parameter, making them more
adaptable since the scale parameter can stretch or com-
press the distribution.
The Log-Normal distribution is a function of the
mean (μ) and standard deviation (s) parameters, and
describes a random variable x where log (x) is normally
distributed. The probability density function of the Log-
Normal distribution can be expressed as follows:
f (x;μ, σ ) =
1
xσ
√
2π
exp
{
−(log x − μ)
2
2σ 2
}
where x > 0 and -∞ < μ < ∞, s > 0 The Gamma dis-
tribution is characterized by a shape () and a scale
parameter (θ), has a mean of θ and a standard devia-
tion of
√
κθ2. The probability density function of the
Gamma distribution can be expressed as follows:
f (x; κ, θ) =
xκ−1
θκ(κ)
exp
{
− x
θ
}
where x > 0,  > 0, θ > 0 and
(κ) =
∞∫
0
tκ−1 exp {−t} dt Similar to the Gamma distri-
bution, the Weibull distribution is commonly character-
ized by a shape (g) and a scale parameter (θ). The
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Weibull distribution has a mean of θ 
(
1
γ
+ 1
)
and a
standard deviation of θ
√

(
2
γ
+ 1
)
− 
(
1
γ
+ 1
)2
,
where  (x) =
∞∫
0
tx−1 exp {−t} dt is the Gamma function
evaluated at x. The probability density function of the
Weibull distribution is expressed as follows:
f (x; θ , γ ) =
γ
θ
( x
θ
)γ−1
exp
{
−
( x
θ
)γ }
where x ≥ 0, g > 0, θ > 0 Maximum likelihood estima-
tion was used to fit all three distribution models to the
drinking population data obtained from GENACIS and
ECAS. All missing values were excluded from the fitted
models. The Newton-Raphson algorithm was used to
optimize the likelihood equations solving for the maxi-
mum likelihood estimates of the unknown parameters
[39]. Data values of alcohol consumption over 300 g/day
were truncated to 300 g/day. Numerical integration uti-
lizing the trapezoidal rule was used to characterize each
distribution.
Method for deriving the alcohol PAF
We performed a sensitivity analysis where the alcohol
PAFs for pancreatitis, diabetes, and breast cancer were
calculated using a continuous model (Log-Normal,
Gamma, and Weibull) and using a categorical model in
order to see if the chosen exposure distribution had an
effect on the estimation of the alcohol PAF. All PAFs
were calculated with zero alcohol consumption as the
counterfactual scenario, similarly to the Comparative
Risk Analysis for alcohol. This counterfactual scenario
under certain circumstances of a light drinking average
alcohol consumption without heavy drinking occasions
may not reflect the theoretical minimum risk depending
on the distribution of diseases and cause of death in a
society. However, for this paper these considerations are
not relevant. The relative risks of lifetime abstainers and
former drinkers for pancreatitis, diabetes, and breast
cancer were obtained from the meta-analysis [40-42].
In order to illustrate that the alcohol PAF estimates
based on the Gamma distribution model deviated only
slightly from the PAF derived from the categorical
model, we calculated the difference between the PAFs
calculated for both models.
Methods for characterizing the gamma distributions
The Gamma distribution can be characterized by a
shape () and a scale parameter (θ), where the mean
and the standard deviation of the Gamma distribution
can be obtained directly from the parameter estimates
as follows:
μ = κθ and σ =
√
κθ2
Since the mean of the Gamma distribution is equal to
the mean of the empirical distribution, the mean of the
Gamma distribution does not need to be estimated from
the shape and scale parameters.
A maximum likelihood algorithm (see description
above) was used to obtain the shape and scale para-
meters using the maximum likelihood function for the
shape and scale parameters of the Gamma distribution:
l(κ, θ) = (κ − 1)
N∑
i=1
ln(xi) −
N∑
i=1
xi
θ
− N · κ · ln(θ) − N · ln((κ))
Regression analysis
The maximum likelihood method was used to fit a
Gamma model in order to summarize the alcohol con-
sumption of 66 countries by gender and age (in total 851
datasets [422 for women; 429 for men]). After the data
was fit by a Gamma model, the relationship between the
Gamma mean and the Gamma standard deviation was
examined using various general linear models. The per-
formance of the general linear models was then assessed
by how well the assumption of homoscedasticity was
upheld and based on the distribution of the residuals.
All data analyses were performed in R version 2.13.0
[43].
Results
Modeling alcohol consumption as a distribution
The three distributions, Log-Normal, Gamma, and Wei-
bull, were fit to 41 datasets; parameter estimates are
outlined in Table 1 for women and in Table 2 for men.
The mean and standard deviation estimates from the
empirical data and the estimates from each fitted model
are summarized in Table 3 for women and in Table 4
for men. When comparing the empirical mean to each
distribution’s mean, we observed that the mean esti-
mates from the Weibull distribution were much closer
to the empirical mean than were the Log-Normal distri-
bution mean estimates, while the mean estimates from
the Gamma distribution were equal to the empirical
mean. When comparing the standard deviation esti-
mates, the estimates from the Log-Normal distribution
deviated furthest from the empirical data, while there
was no statistically significant difference between the
empirical standard deviation estimate and the standard
deviation estimates from either of the Weibull or the
Gamma distributions.
Three countries with diverse economic conditions and
drinking patterns, namely Germany, Sri Lanka, and
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Uganda, were selected to display their density curves
(Log-Normal, Gamma, and Weibull) superimposed on
the population-based data histograms; see Figures 1, 2,
3, 4, 5, and 6 for both women and men. We observed a
common trend among men in Figures 2, 4, and 6: the
Log-Normal distribution tended to underestimate the
number of men who drank 25 g/day to 50 g/day,
whereas the Gamma and Weibull distributions accu-
rately estimated alcohol consumption for these popula-
tions. A similar trend was observed with respect to
Table 1 Parameter estimates from Log-Normal, Gamma, and Weibull models for women from 43 datasets
Log-Normal model parameter estimates Gamma model parameter estimates Weibull model parameter estimates
Country Mean Standard deviation Scale Shape Scale Shape
Argentina 0.14 1.93 9.17 0.48 2.92 0.60
Australia 0.57 1.88 11.75 0.51 4.33 0.64
Australia 1 0.47 1.57 8.57 0.56 3.55 0.67
Austria 1.91 0.92 8.45 1.26 10.85 1.05
Belize 0.64 1.51 13.44 0.50 4.17 0.62
Brazil 1.09 2.10 36.30 0.41 8.18 0.54
Canada 1.06 1.41 9.92 0.69 5.78 0.77
Costa Rica -0.28 1.81 7.20 0.45 1.88 0.57
Czech Republic 1.04 1.70 16.47 0.54 6.49 0.66
Denmark 1.37 1.40 9.37 0.84 7.46 0.89
ECAS: Finland 1.07 1.20 6.51 0.88 5.26 0.87
ECAS: France 0.94 1.56 10.94 0.63 5.51 0.72
ECAS: Germany 1.05 1.34 9.21 0.72 5.53 0.78
ECAS: Italy 1.37 1.59 15.91 0.64 8.45 0.74
ECAS: Sweden 0.90 1.17 4.23 1.02 4.30 0.99
ECAS: UK 1.70 1.48 19.03 0.69 11.13 0.77
Finland 0.47 1.67 7.08 0.61 3.47 0.72
France 1.62 1.05 9.30 0.98 8.75 0.92
Germany 1.30 1.47 12.42 0.70 7.43 0.78
Hungary -0.82 1.89 4.36 0.44 1.11 0.58
Iceland 0.82 1.31 5.78 0.81 4.23 0.84
India 1.31 2.16 42.29 0.42 10.39 0.55
Ireland 2.01 1.23 15.55 0.91 13.53 0.91
Isle of Man 1.18 1.85 16.98 0.57 7.59 0.69
Israel -0.05 1.98 12.55 0.40 2.52 0.54
Italy 1.52 1.39 12.97 0.77 8.95 0.83
Japan -0.15 2.18 14.32 0.37 2.53 0.50
Kazakhstan -0.52 1.93 6.67 0.42 1.52 0.56
Mexico -1.15 1.63 5.03 0.37 0.76 0.53
Netherlands 1.44 1.11 8.33 0.94 7.43 0.91
Nicaragua 0.91 1.49 26.83 0.43 5.54 0.57
Nigeria 1.84 2.31 65.85 0.43 18.29 0.56
Norway 0.61 1.58 7.07 0.66 3.85 0.75
Peru 0.16 0.91 1.62 1.18 1.89 0.98
Spain 1.07 1.78 13.31 0.61 6.58 0.72
Sri Lanka -2.28 1.69 3.31 0.30 0.27 0.46
Sweden 0.44 1.26 4.15 0.79 2.93 0.83
Switzerland 1.39 1.25 8.07 0.93 7.21 0.93
Uganda 0.98 2.09 34.50 0.40 7.39 0.53
Uruguay 0.19 1.90 11.60 0.45 3.10 0.58
USA 1 0.18 1.96 12.42 0.43 3.16 0.56
USA 2 0.30 1.62 11.49 0.47 3.12 0.59
USA 3 0.23 1.67 9.85 0.48 2.94 0.61
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women from Germany and Uganda who drank between
10 g/day to 30 g/day and for Sri Lankan women who
drank between 0.5 g/day to 2.0 g/day.
Alcohol PAF estimates modeled using the Log-Nor-
mal, Gamma, and Weibull distributions, together with
the proportion estimates for lifetime abstainers and for-
mer drinkers, are listed in Table 5 for breast cancer
(women), Tables 6 and 7 for diabetes (women and men,
respectively), and Tables 8 and 9 for pancreatitis
(women and men, respectively).
The alcohol PAF estimates that incorporated the
Gamma and Weibull distributions are very similar and,
for the most part, are within 1% of one another. Since
the Log-Normal distribution is known to have a heavy
tail, and this study includes data values for alcohol con-
sumption up to 300 g/day, the alcohol PAF estimates
Table 2 Parameter estimates from Log-Normal, Gamma, and Weibull models for men from 41 datasets
Log-Normal model parameter estimates Gamma model parameter estimates Weibull model parameter estimates
Country Mean Standard deviation Scale Shape Scale Shape
Argentina 1.84 1.68 25.33 0.64 13.62 0.75
Australia 1.63 1.69 18.79 0.67 10.99 0.78
Austria 2.85 0.96 19.72 1.33 27.52 1.13
Belize 2.06 1.55 37.69 0.59 16.85 0.69
Brazil 1.57 2.01 47.07 0.44 12.55 0.57
Canada 1.96 1.42 21.64 0.74 14.04 0.81
Costa Rica 1.13 1.87 23.50 0.49 7.71 0.61
Czech Republic 2.58 1.55 38.84 0.75 26.59 0.83
Denmark 2.28 1.24 18.05 0.98 17.33 0.96
ECAS: Finland 2.22 1.18 16.68 0.99 16.13 0.95
ECAS: France 2.18 1.48 26.19 0.75 17.56 0.82
ECAS: Germany 1.92 1.33 16.43 0.84 12.84 0.87
ECAS: Italy 2.22 1.40 20.68 0.87 17.43 0.92
ECAS: Sweden 1.79 1.26 13.48 0.87 10.94 0.88
ECAS: UK 2.85 1.30 38.19 0.88 31.78 0.90
Finland 1.76 1.51 17.08 0.75 11.58 0.83
France 2.44 1.25 25.29 0.88 21.08 0.90
Germany 2.27 1.37 21.29 0.88 18.07 0.92
Hungary 1.10 1.81 17.13 0.55 6.95 0.67
Iceland 1.64 1.25 9.84 0.96 9.17 0.95
India 2.24 1.95 69.20 0.49 23.75 0.62
Ireland 3.04 1.18 38.57 0.98 36.94 0.95
Isle of Man 2.22 1.78 39.38 0.63 20.51 0.74
Israel 1.02 1.87 22.11 0.48 6.85 0.61
Italy 2.44 1.30 21.80 0.96 20.92 0.99
Japan 1.63 2.19 37.45 0.49 13.60 0.63
Kazakhstan 1.87 1.76 36.80 0.55 14.69 0.67
Mexico 1.34 1.90 33.23 0.46 9.68 0.59
Netherlands 2.28 1.17 17.45 1.00 17.27 0.98
Nicaragua 2.03 1.52 38.43 0.58 16.28 0.68
Nigeria 2.47 1.78 55.90 0.60 26.97 0.71
Norway 1.66 1.44 15.92 0.74 10.25 0.80
Peru 1.13 1.17 8.89 0.76 5.60 0.79
Spain 2.28 1.49 25.30 0.81 19.04 0.87
Sri Lanka 1.30 2.18 57.93 0.37 10.71 0.51
Sweden 1.12 1.32 8.20 0.79 5.83 0.83
Switzerland 2.37 1.12 17.65 1.05 18.27 0.97
Uganda 2.75 1.79 70.07 0.61 35.42 0.73
Uruguay 1.69 1.84 34.78 0.52 12.88 0.64
USA 2 1.41 1.72 25.65 0.53 9.50 0.64
USA 3 1.32 1.80 28.58 0.49 9.04 0.61
Kehoe et al. Population Health Metrics 2012, 10:6
http://www.pophealthmetrics.com/content/10/1/6
Page 6 of 19
Table 3 Mean and standard deviation estimates from the empirical data, Log-Normal model, Gamma model, and the
Weibull model for alcohol consumption of women from 43 datasets
Empirical data Log-Normal model Gamma model Weibull model
Country Count Mean Standard deviation Mean Standard deviation Mean Standard deviation Mean Standard deviation
Argentina 381 4.38 6.77 7.35 46.50 4.38 6.34 4.39 7.69
Australia 1172 6.04 9.52 10.40 60.39 6.04 8.42 6.06 9.90
Australia 1 3002 4.84 7.81 5.47 17.86 4.84 6.44 4.69 7.22
Austria 1916 10.62 13.26 10.36 11.94 10.62 9.47 10.66 10.20
Belize 386 6.74 16.63 5.92 17.44 6.74 9.52 5.98 10.02
Brazil 283 14.80 29.63 26.75 240.21 14.80 23.18 14.27 28.60
Canada 5850 6.88 10.79 7.82 19.76 6.88 8.26 6.75 8.90
Costa Rica 367 3.21 6.33 3.90 19.86 3.21 4.81 3.00 5.57
Czech Republic 1023 8.97 15.12 12.08 50.02 8.97 12.16 8.74 13.71
Denmark 1042 7.89 8.85 10.48 26.03 7.89 8.59 7.89 8.85
ECAS: Finland 469 5.71 9.65 6.00 10.77 5.71 6.09 5.63 6.47
ECAS: France 382 6.85 9.83 8.64 27.71 6.85 8.66 6.77 9.54
ECAS: Germany 512 6.93 21.77 7.05 15.85 6.62 7.80 6.39 8.30
ECAS: Italy 404 10.23 14.99 14.08 48.17 10.23 12.76 10.17 13.94
ECAS: Sweden 433 4.32 4.58 4.87 8.35 4.32 4.28 4.32 4.36
ECAS: UK 498 13.14 19.31 16.34 46.06 13.14 15.81 12.97 17.02
Finland 882 4.35 7.83 6.45 25.27 4.35 5.55 4.28 6.07
France 4206 9.14 11.79 8.78 12.42 9.14 9.22 9.08 9.83
Germany 4164 8.72 12.97 10.88 30.24 8.72 10.41 8.60 11.17
Hungary 883 1.92 5.31 2.62 15.31 1.92 2.90 1.75 3.22
Iceland 1072 4.70 7.41 5.34 11.37 4.70 5.21 4.63 5.53
India 85 17.67 26.94 38.01 388.74 17.67 27.33 17.88 35.44
Ireland 378 14.20 17.69 16.05 30.35 14.20 14.86 14.14 15.54
Isle of Man 469 9.67 13.20 17.91 97.33 9.67 12.81 9.77 14.57
Israel 1938 4.98 12.52 6.70 46.91 4.98 7.91 4.46 9.04
Italy 1219 9.93 11.72 11.91 28.76 9.93 11.35 9.90 12.01
Japan 864 5.27 11.72 9.17 97.39 5.27 8.68 5.02 11.15
Kazakhstan 401 2.80 7.91 3.78 23.87 2.80 4.32 2.50 4.78
Mexico 1406 1.88 7.32 1.20 4.39 1.88 3.07 1.37 2.82
Netherlands 1505 7.84 10.50 7.83 12.20 7.84 8.08 7.78 8.58
Nicaragua 147 11.43 34.88 7.52 21.56 11.43 17.51 8.94 16.78
Nigeria 200 28.45 41.91 91.55 1322.58 28.45 43.28 30.12 57.50
Norway 1004 4.64 7.03 6.39 21.38 4.64 5.73 4.59 6.21
Peru 620 1.91 3.07 1.78 2.03 1.91 1.76 1.90 1.95
Spain 427 8.07 11.17 14.34 69.00 8.07 10.36 8.12 11.50
Sri Lanka 38 1.00 2.93 0.42 1.70 1.00 1.82 0.64 1.63
Sweden 2226 3.29 4.51 3.42 6.75 3.29 3.69 3.24 3.94
Switzerland 5362 7.50 10.07 8.77 17.04 7.50 7.78 7.48 8.09
Uganda 280 13.78 26.60 23.46 206.14 13.78 21.80 13.25 27.17
Uruguay 375 5.17 12.02 7.35 43.87 5.17 7.75 4.91 9.05
USA 1 854 5.37 10.39 8.11 54.33 5.37 8.17 5.21 9.95
USA 2 1310 5.35 14.44 5.00 17.90 5.35 7.84 4.76 8.46
USA 3 2274 4.75 10.65 5.09 19.93 4.75 6.84 4.36 7.57
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from the Log-Normal distribution tend to be much lar-
ger and unrealistic when compared to the estimates
from the Gamma and Weibull distributions.
Overall, the PAF estimates from the categorical model,
Gamma model, and Weibull model are relatively similar
when the survey data are more compact, but for those
Table 4 Mean and standard deviation estimates from the empirical data, Log-Normal model, Gamma model, and the
Weibull model for alcohol consumption of men from 41 datasets
Empirical data Log-Normal model Gamma model Weibull model
Country Count Mean Standard deviation Mean Standard deviation Mean Standard deviation Mean Standard deviation
Argentina 359 16.26 21.80 25.79 102.88 16.26 20.29 16.29 22.18
Australia 882 12.63 15.09 21.31 86.21 12.63 15.40 12.73 16.58
Austria 2697 26.23 26.25 27.23 33.35 26.23 22.75 26.35 23.43
Belize 957 22.52 41.05 26.19 83.46 22.31 29.00 21.51 31.79
Brazil 325 20.78 37.89 35.81 265.46 20.78 31.27 20.16 37.64
Canada 4833 16.09 24.60 19.65 50.51 16.02 18.62 15.84 19.82
Costa Rica 285 11.47 18.97 17.91 101.55 11.47 16.42 11.30 19.36
Czech Republic 1121 29.19 32.98 43.56 137.44 29.19 33.67 29.27 35.28
Denmark 865 17.68 21.18 21.03 39.93 17.68 17.87 17.66 18.42
ECAS: Finland 462 16.53 21.56 18.48 32.09 16.53 16.60 16.49 17.32
ECAS: France 415 19.75 28.51 26.44 74.41 19.66 22.69 19.55 23.98
ECAS: Germany 328 13.81 19.83 16.65 36.89 13.81 15.06 13.73 15.76
ECAS: Italy 434 18.06 19.09 24.71 61.39 18.06 19.33 18.08 19.57
ECAS: Sweden 449 11.77 17.59 13.28 26.13 11.77 12.60 11.66 13.29
ECAS: UK 361 34.95 54.61 40.33 85.07 33.62 35.83 33.48 37.34
Finland 864 12.88 17.32 18.14 53.44 12.88 14.83 12.84 15.63
France 4697 22.24 25.21 24.83 47.92 22.24 23.72 22.18 24.67
Germany 3510 18.79 20.74 24.77 58.38 18.79 20.00 18.79 20.45
Hungary 991 9.38 15.16 15.50 78.87 9.38 12.68 9.25 14.34
Iceland 1013 9.42 11.04 11.18 21.62 9.42 9.63 9.40 9.94
India 498 34.82 54.78 63.16 417.87 34.20 48.65 34.40 58.26
Ireland 385 37.82 43.73 42.23 73.86 37.82 38.19 37.74 39.61
Isle of Man 420 24.90 36.39 45.31 217.60 24.64 31.15 24.77 34.16
Israel 2005 10.59 19.71 15.91 89.50 10.59 15.30 10.19 17.71
Italy 1429 20.98 19.35 26.89 56.90 20.98 21.39 20.98 21.13
Japan 1009 18.51 25.29 55.72 605.09 18.51 26.33 19.42 32.43
Kazakhstan 401 20.55 40.31 30.49 139.45 20.27 27.31 19.50 30.13
Mexico 1833 15.48 30.37 23.46 141.72 15.37 22.60 14.86 26.61
Netherlands 1679 17.47 18.78 19.46 33.31 17.47 17.46 17.46 17.89
Nicaragua 263 22.26 40.29 24.27 73.44 22.26 29.25 21.16 31.91
Nigeria 439 33.63 45.76 58.17 279.62 33.38 43.19 33.66 48.39
Norway 945 11.78 19.42 14.67 38.42 11.78 13.70 11.59 14.57
Peru 425 6.76 15.68 6.10 10.43 6.76 7.75 6.42 8.24
Spain 603 20.44 24.47 29.64 84.47 20.44 22.74 20.43 23.56
Sri Lanka 323 21.87 43.99 39.56 426.76 21.65 35.42 20.87 45.74
Sweden 2348 6.49 9.17 7.30 15.79 6.49 7.30 6.42 7.74
Switzerland 5126 18.55 24.86 20.15 32.01 18.54 18.09 18.50 19.05
Uganda 378 42.93 52.50 78.02 382.06 42.80 54.76 43.42 61.01
Uruguay 305 18.32 34.55 29.22 154.64 18.16 25.14 17.75 28.56
USA 2 1499 13.51 24.00 17.81 75.66 13.51 18.62 13.12 21.16
USA 3 2300 14.18 32.43 19.12 95.29 13.93 19.95 13.20 22.54
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countries where data are more spread out, PAF esti-
mates are more susceptible to sampling bias for diseases
with a relatively linear or exponential risk relationship
with alcohol, such as pancreatitis and breast cancer. For
example, for Brazilian men the alcohol consumption
prevalence data tend to be very spread out when com-
pared to men from France, leading to a small difference
in the PAFs for pancreatitis. However, this trend does
not apply when we look at a disease, such as diabetes,
that has a J-shaped relative risk function. If we look at
the same example, we find that the alcohol PAFs for dia-
betes provide similar estimates from the categorical
model, Gamma model, Log-Normal model, and Weibull
model for men from both Brazil and France. This is due
to the fact that the relative risk functions are exponential
Figure 1 Alcohol consumption distribution in grams per day of
pure alcohol for women in Germany. Alcohol consumption
distribution in grams per day of pure alcohol for women in
Germany.
Figure 2 Alcohol consumption distribution in grams per day of
pure alcohol for men in Germany.
Figure 3 Alcohol consumption distribution in grams per day of
pure alcohol for women in Sri Lanka.
Figure 4 Alcohol consumption distribution in grams per day of
pure alcohol for men in Sri Lanka. Alcohol consumption
distribution in grams per day of pure alcohol for men in Sri Lanka.
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for pancreatitis and are J-shaped for diabetes and thus
have different properties. The J-shaped curve in some
cases leads to a negative PAF (which represents the frac-
tion of deaths prevented) as the risk of diabetes at the
population level is less under current levels of alcohol
consumption than under the counterfactual scenario of
no alcohol consumption.
Characterizing the alcohol consumption gamma
distribution
Based on data from GENACIS and STEPS, the mean
daily average per capita alcohol consumption among
drinkers was estimated to be 7.549 grams for women
(the Gamma standard deviation was 9.862) and 18.292
grams for men (the Gamma standard deviation was
22.015) (see Table 10).
After analyzing the association between the Gamma
mean and the Gamma standard deviation, a strong lin-
ear relationship was established. Analysis of the resi-
duals of various general linear models led to the
conclusion that a general linear model with a normal
distribution and an identity link (i.e., a linear regression
model) is the best possible model to characterize the
relationship between the standard deviation of the
Gamma distribution and the mean of the Gamma dis-
tribution. As a statistical interaction was determined to
be present by gender for the relationship between the
Gamma mean and the Gamma standard deviation, this
linear relationship was modeled separately for men and
for women.
Figures 7 and 8 illustrate the linear fit for women
and men, respectively. The linear regressions indicate
that a unit increase in mean alcohol consumption is
associated with an increase of 1.258 (95% CI: 1.223 to
1.293) in the standard deviation of the Gamma alcohol
consumption distribution for women and 1.171 (95%
CI: 1.144 to 1.197) in the standard deviation of the
Gamma alcohol consumption distribution for men.
Additionally, for women the linear regression indicated
that 92.07% of the variation of the standard deviation
of the Gamma distribution was explained by the mean,
while for men 94.74% of the variation of the standard
deviation of the Gamma distribution was explained by
the mean.
Regression diagnostics indicated that there were some
outliers. For women, two data points from Nigeria and
one from Uganda were identified as influential observa-
tions, while for men, two observations in Germany and
one in Nigeria were identified as influential observations.
There was no indication of a lack of homoscedasticity
for any of the regression models (Additional file 1).
Discussion
Both the Gamma and the Weibull distributions sum-
marized the population distribution of average volume
of alcohol consumption more accurately than did the
Log-Normal distribution. Moreover, for the Gamma and
Weibull distributions the ratio of mean to standard
deviation was comparable across all countries, irrespec-
tive of drinking patterns and the survey measure used to
measure alcohol consumption. Overall, both the Gamma
and Weibull distributions yield similar PAFs and could
Figure 5 Alcohol consumption distribution in grams per day of
pure alcohol for women in Uganda.
Figure 6 Alcohol consumption distribution in grams per day of
pure alcohol for men in Uganda.
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be used in descriptive alcohol epidemiology. Although
not examined specifically, these outcomes would also
apply to PAFs that are calculated when using a counter-
factual scenario where alcohol consumption is decreased
due to a policy or intervention such as taxation. Since
the Weibull distribution is a more complicated distribu-
tion and less flexible than the Gamma distribution, and
since it is possible to shift the Gamma distribution
Table 5 Proportion estimates for lifetime abstainers and former drinkers, as well as Population-Attributable Fraction
(PAF) estimates for breast cancer using a categorical model and continuous models (Gamma, Log-Normal, and
Weibull) for women
Proportions PAF estimates
Country Abstainers Former drinkers Categorical Gamma model Log-Normal model Weibull model PAFcategorical - PAFgamma
Argentina 0.06355 0.29933 0.14923 0.1354 0.15384 0.1362 0.01383
Australia 0.04951 0.13319 0.10734 0.09444 0.12996 0.096 0.0129
Australia 1 0.12341 0.06414 0.08152 0.06024 0.07021 0.05996 0.02128
Austria 0.17941 0.3288 0.16652 0.16302 0.1632 0.16338 0.0035
Belize 0.59903 0.21449 0.10145 0.09595 0.09592 0.0951 0.0055
Brazil 0.22741 0.36006 0.19526 0.18374 0.20113 0.18618 0.01152
Canada 0.09532 0.16116 0.1189 0.10649 0.11779 0.10619 0.01241
Costa Rica 0.19253 0.37923 0.16137 0.15162 0.15593 0.15135 0.00975
Czech Republic 0.05538 0.14665 0.13325 0.11822 0.14643 0.11888 0.01503
Denmark 0.00971 0.07061 0.10045 0.09091 0.12153 0.0911 0.00954
ECAS: Finland 0.0748 0.00197 0.06369 0.0474 0.05292 0.04699 0.01629
ECAS: France 0.27238 0 0.05939 0.04492 0.06499 0.04519 0.01447
ECAS: Germany 0.18471 0 0.07463 0.04827 0.05679 0.0471 0.02636
ECAS: Italy 0.21206 0.00195 0.08903 0.07422 0.11217 0.07535 0.01481
ECAS: Sweden 0.132 0.002 0.04803 0.03386 0.03994 0.03388 0.01417
ECAS: UK 0.14286 0 0.11594 0.10312 0.13957 0.10394 0.01282
Finland 0.06491 0.04057 0.06973 0.05056 0.07463 0.05056 0.01917
France 0.03552 0.41525 0.19287 0.18747 0.18762 0.18745 0.0054
Germany 0.02588 0.03691 0.10094 0.08681 0.11568 0.08677 0.01413
Hungary 0.17718 0.05964 0.06264 0.03701 0.0453 0.0363 0.02563
Iceland 0.07396 0.08261 0.08375 0.06784 0.07546 0.0675 0.01591
India 0.84014 0.10204 0.05502 0.05365 0.05764 0.05469 0.00137
Ireland 0.23933 0.05937 0.1181 0.11259 0.1345 0.11288 0.00551
Isle of Man 0.01838 0.11949 0.12723 0.1185 0.1757 0.12157 0.00873
Israel 0.42882 0 0.04408 0.02458 0.0391 0.02325 0.0195
Italy 0.19622 0.06094 0.10517 0.0899 0.11227 0.09029 0.01527
Japan 0.15058 0.08415 0.0886 0.06775 0.09511 0.06877 0.02085
Kazakhstan 0.10143 0.26307 0.13401 0.11568 0.12401 0.11479 0.01833
Mexico 0.40553 0.17212 0.09092 0.07588 0.07463 0.07449 0.01504
Netherlands 0.14467 0.17495 0.12055 0.11305 0.11531 0.11294 0.0075
Nicaragua 0.50282 0.39336 0.16442 0.15622 0.15366 0.15459 0.0082
Nigeria 0.56034 0.2298 0.16004 0.15402 0.16134 0.15696 0.00602
Norway 0.04049 0.0757 0.08266 0.0662 0.08621 0.06621 0.01646
Peru 0.08966 0.29951 0.13924 0.1245 0.12399 0.12449 0.01474
Spain 0.22908 0.32427 0.1547 0.15056 0.17495 0.15131 0.00414
Sri Lanka 0.8661 0.06949 0.03264 0.03012 0.02992 0.02995 0.00252
Sweden 0.09666 0.1123 0.08539 0.06797 0.06996 0.06777 0.01742
Switzerland 0.19806 0.06082 0.08298 0.07341 0.08702 0.0734 0.00957
Uganda 0.36412 0.26649 0.15735 0.14658 0.1619 0.14889 0.01077
Uruguay 0.17308 0.22596 0.12907 0.11302 0.12813 0.11289 0.01605
USA 1 0.10302 0.13854 0.10544 0.089 0.11203 0.08978 0.01644
USA 2 0.3263 0.18852 0.11255 0.09623 0.09806 0.09469 0.01632
USA 3 0.38019 0.05805 0.06399 0.04719 0.05318 0.04608 0.0168
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upwards (necessary in modeling the burden of disease
attributable to alcohol consumption), the Gamma distri-
bution is the best distribution for modeling alcohol
consumption.
Modeling survey alcohol consumption data alone with-
out correcting the distribution for undercoverage will
lead to inaccurate alcohol PAFs as self-reported survey
data typically underestimate alcohol consumption based
Table 6 Proportion estimates for lifetime abstainers and former drinkers, as well as Population-Attributable Fraction
(PAF) estimates for diabetes using a categorical model and continuous models (Gamma, Log-Normal, and Weibull) for
women
Proportions PAF estimates
Country Abstainers Former drinkers Categorical Gamma model Log-Normal model Weibull model PAFcategorical - PAFgamma
Argentina 0.06355 0.29933 -0.14692 -0.06787 -0.05274 -0.06333 -0.07905
Australia 0.04951 0.13319 -0.24721 -0.15762 -0.12626 -0.15022 -0.08959
Australia 1 0.12341 0.06414 -0.2699 -0.16237 -0.14117 -0.15421 -0.10753
Austria 0.17941 0.3288 -0.10003 -0.09967 -0.09292 -0.09467 -0.00036
Belize 0.59903 0.21449 -0.01794 -0.00596 -0.00215 -0.0034 -0.01198
Brazil 0.22741 0.36006 -0.05408 -0.02384 -0.01732 -0.02246 -0.03024
Canada 0.09532 0.16116 -0.21615 -0.16259 -0.13959 -0.15557 -0.05356
Costa Rica 0.19253 0.37923 -0.06097 -0.00801 -0.00214 -0.00435 -0.05296
Czech Republic 0.05538 0.14665 -0.23423 -0.17322 -0.14215 -0.16336 -0.06101
Denmark 0.00971 0.07061 -0.33046 -0.26493 -0.22239 -0.26241 -0.06553
ECAS: Finland 0.0748 0.00197 -0.32158 -0.25101 -0.22964 -0.24296 -0.07057
ECAS: France 0.27238 0 -0.25029 -0.18164 -0.15523 -0.17478 -0.06865
ECAS: Germany 0.18471 0 -0.2797 -0.21639 -0.19186 -0.20633 -0.06331
ECAS: Italy 0.21206 0.00195 -0.2856 -0.21937 -0.1826 -0.21217 -0.06623
ECAS: Sweden 0.132 0.002 -0.29211 -0.20986 -0.19889 -0.20854 -0.08225
ECAS: UK 0.14286 0 -0.30489 -0.25529 -0.22162 -0.24719 -0.0496
Finland 0.06491 0.04057 -0.29456 -0.18499 -0.16109 -0.18021 -0.10957
France 0.03552 0.41525 -0.10183 -0.08985 -0.08062 -0.08479 -0.01198
Germany 0.02588 0.03691 -0.33041 -0.26864 -0.22619 -0.25848 -0.06177
Hungary 0.17718 0.05964 -0.22547 -0.08457 -0.08059 -0.07914 -0.1409
Iceland 0.07396 0.08261 -0.26082 -0.18598 -0.16929 -0.18056 -0.07484
India 0.84014 0.10204 0.0037 0.00412 0.00483 0.00417 -0.00042
Ireland 0.23933 0.05937 -0.21416 -0.21209 -0.18943 -0.20603 -0.00207
Isle of Man 0.01838 0.11949 -0.27038 -0.20513 -0.15778 -0.19787 -0.06525
Israel 0.42882 0 -0.17003 -0.09966 -0.08491 -0.09059 -0.07037
Italy 0.19622 0.06094 -0.25978 -0.2077 -0.17787 -0.20246 -0.05208
Japan 0.15058 0.08415 -0.23347 -0.11957 -0.09699 -0.10624 -0.1139
Kazakhstan 0.10143 0.26307 -0.14039 -0.04881 -0.04103 -0.0426 -0.09158
Mexico 0.40553 0.17212 -0.08857 -0.02026 -0.01479 -0.01363 -0.06831
Netherlands 0.14467 0.17495 -0.18932 -0.16501 -0.15025 -0.15897 -0.02431
Nicaragua 0.50282 0.39336 0.02923 0.03438 0.03458 0.03517 -0.00515
Nigeria 0.56034 0.2298 -0.00892 0.00013 -0.00065 -0.00187 -0.00905
Norway 0.04049 0.0757 -0.28376 -0.18535 -0.16146 -0.18067 -0.09841
Peru 0.08966 0.29951 -0.12528 -0.04802 -0.04493 -0.04558 -0.07726
Spain 0.22908 0.32427 -0.07944 -0.05418 -0.03553 -0.05184 -0.02526
Sri Lanka 0.8661 0.06949 -0.00659 0.00516 0.00598 0.00625 -0.01175
Sweden 0.09666 0.1123 -0.23299 -0.13662 -0.12713 -0.13302 -0.09637
Switzerland 0.19806 0.06082 -0.24288 -0.20449 -0.18102 -0.20067 -0.03839
Uganda 0.36412 0.26649 -0.05139 -0.02926 -0.02312 -0.02722 -0.02213
Uruguay 0.17308 0.22596 -0.14518 -0.07583 -0.06006 -0.06876 -0.06935
USA 1 0.10302 0.13854 -0.22157 -0.12244 -0.1 -0.11227 -0.09913
USA 2 0.3263 0.18852 -0.11105 -0.06216 -0.05102 -0.05505 -0.04889
USA 3 0.38019 0.05805 -0.16022 -0.09638 -0.08313 -0.08908 -0.06384
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on sales or taxation (e.g., [26]). In other words, alcohol
surveys often do not accurately represent the population
due to undercoverage where some members of the popu-
lation are inadequately represented (or excluded) or due
to response bias [30]. Accordingly, a method must be
developed that will shift the exposure distribution so that
it is consistent with per capita consumption data in order
to correct for survey bias and allow for a more accurate
Table 7 Proportion estimates for lifetime abstainers and former drinkers, as well as Population-Attributable Fraction
(PAF) estimates for diabetes using a categorical model and continuous models (Gamma, Log-Normal, and Weibull) for
men
Proportions PAF estimates
Country Abstainers Former drinkers Categorical Gamma model Log-Normal model Weibull model PAFcategorical - PAFgamma
Argentina 0.02488 0.08209 -0.06204 -0.04912 -0.03488 -0.04748 -0.01292
Australia 0.04 0.078 -0.06679 -0.05195 -0.03473 -0.05064 -0.01484
Austria 0.07014 0.15774 -0.03393 -0.0344 -0.03358 -0.03185 0.00047
Belize 0.20958 0.28647 0.01671 0.02142 0.02176 0.02153 -0.00471
Brazil 0.14516 0.2724 0.01291 0.01974 0.0221 0.01964 -0.00683
Canada 0.05019 0.1359 -0.04406 -0.03732 -0.02801 -0.03536 -0.00674
Costa Rica 0.07212 0.24279 -0.00984 0.00218 0.01119 0.00484 -0.01202
Czech Republic 0.02653 0.07235 -0.04347 -0.03926 -0.03536 -0.04003 -0.00421
Denmark 0.00669 0.02899 -0.08567 -0.08015 -0.06768 -0.0783 -0.00552
ECAS: Finland 0.06855 0 -0.08737 -0.0843 -0.07434 -0.08173 -0.00307
ECAS: France 0.12632 0 -0.07771 -0.06634 -0.05575 -0.06515 -0.01137
ECAS: Germany 0.11828 0 -0.08546 -0.07494 -0.06289 -0.073 -0.01052
ECAS: Italy 0.107 0 -0.08652 -0.07515 -0.06007 -0.07519 -0.01137
ECAS: Sweden 0.07803 0 -0.08431 -0.07873 -0.06794 -0.07597 -0.00558
ECAS: UK 0.10422 0 -0.06259 -0.04982 -0.05368 -0.04976 -0.01277
Finland 0.03181 0.05196 -0.07492 -0.06375 -0.04797 -0.06205 -0.01117
France 0.01975 0.2008 -0.02168 -0.0214 -0.01805 -0.02032 -0.00028
Germany 0.01415 0.03101 -0.08136 -0.07386 -0.05941 -0.07326 -0.0075
Hungary 0.04696 0.04052 -0.07032 -0.0531 -0.03804 -0.04984 -0.01722
Iceland 0.04117 0.09005 -0.06259 -0.05392 -0.04428 -0.05279 -0.00867
India 0.56138 0.10816 0.00549 0.00725 0.00506 0.0058 -0.00176
Ireland 0.16501 0.06958 -0.03008 -0.02443 -0.03142 -0.02394 -0.00565
Isle of Man 0.00885 0.06195 -0.05799 -0.0442 -0.03528 -0.04466 -0.01379
Israel 0.23209 0 -0.06315 -0.048 -0.03712 -0.04455 -0.01515
Italy 0.05808 0.03977 -0.07456 -0.06762 -0.05524 -0.06853 -0.00694
Japan 0.04869 0.04148 -0.06659 -0.04611 -0.03092 -0.04448 -0.02048
Kazakhstan 0.04267 0.21336 -0.01315 -0.0054 -0.0001 -0.00513 -0.00775
Mexico 0.09404 0.13644 -0.03411 -0.01966 -0.01217 -0.01758 -0.01445
Netherlands 0.06032 0.10269 -0.05643 -0.0539 -0.04592 -0.05264 -0.00253
Nicaragua 0.12052 0.45114 0.05098 0.0533 0.05278 0.05332 -0.00232
Nigeria 0.41863 0.18445 0.0144 0.0159 0.01485 0.01489 -0.0015
Norway 0.02321 0.06286 -0.06847 -0.06023 -0.04747 -0.05749 -0.00824
Peru 0.03488 0.14147 -0.04085 -0.02909 -0.02334 -0.02555 -0.01176
Spain 0.09172 0.23378 -0.0116 -0.0071 0.00214 -0.00672 -0.0045
Sri Lanka 0.19403 0.27032 0.01625 0.02531 0.02578 0.02476 -0.00906
Sweden 0.05049 0.06481 -0.06583 -0.04793 -0.04038 -0.0462 -0.0179
Switzerland 0.06763 0.0412 -0.07542 -0.07214 -0.06481 -0.06895 -0.00328
Uganda 0.28611 0.18889 0.01732 0.01764 0.01246 0.01555 -0.00032
Uruguay 0.04787 0.14096 -0.03916 -0.02318 -0.01523 -0.02209 -0.01598
USA 2 0.16125 0.1617 -0.02577 -0.01383 -0.0064 -0.01152 -0.01194
USA 3 0.26011 0.0707 -0.04069 -0.02818 -0.02105 -0.0261 -0.01251
USA 2 0.3263 0.18852 -0.11105 -0.06216 -0.05102 -0.05505 -0.04889
USA 3 0.38019 0.05805 -0.16022 -0.09638 -0.08313 -0.08908 -0.06384
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estimation of the true alcohol consumption distribution
and for an accurate comparison of the alcohol-attributa-
ble burden of disease across countries.
Given the relationship between the mean and the stan-
dard deviation of alcohol consumption [15], modeling
alcohol consumption using the Gamma distribution, up-
Table 8 Proportion estimates for lifetime abstainers and former drinkers, as well as Population-Attributable Fraction
(PAF) estimates for pancreatitis using a categorical model and continuous models (Gamma, Log-Normal, and Weibull)
for women
Proportions PAF estimates
Country Abstainers Former drinkers Categorical Gamma model Log-Normal model Weibull model PAFcategorical - PAFgamma
Argentina 0.02488 0.08209 -0.06204 -0.04912 -0.03488 -0.04748 -0.01292
Australia 0.04 0.078 -0.06679 -0.05195 -0.03473 -0.05064 -0.01484
Austria 0.07014 0.15774 -0.03393 -0.0344 -0.03358 -0.03185 0.00047
Belize 0.20958 0.28647 0.01671 0.02142 0.02176 0.02153 -0.00471
Brazil 0.14516 0.2724 0.01291 0.01974 0.0221 0.01964 -0.00683
Canada 0.05019 0.1359 -0.04406 -0.03732 -0.02801 -0.03536 -0.00674
Costa Rica 0.07212 0.24279 -0.00984 0.00218 0.01119 0.00484 -0.01202
Czech Republic 0.02653 0.07235 -0.04347 -0.03926 -0.03536 -0.04003 -0.00421
Denmark 0.00669 0.02899 -0.08567 -0.08015 -0.06768 -0.0783 -0.00552
ECAS: Finland 0.06855 0 -0.08737 -0.0843 -0.07434 -0.08173 -0.00307
ECAS: France 0.12632 0 -0.07771 -0.06634 -0.05575 -0.06515 -0.01137
ECAS: Germany 0.11828 0 -0.08546 -0.07494 -0.06289 -0.073 -0.01052
ECAS: Italy 0.107 0 -0.08652 -0.07515 -0.06007 -0.07519 -0.01137
ECAS: Sweden 0.07803 0 -0.08431 -0.07873 -0.06794 -0.07597 -0.00558
ECAS: UK 0.10422 0 -0.06259 -0.04982 -0.05368 -0.04976 -0.01277
Finland 0.03181 0.05196 -0.07492 -0.06375 -0.04797 -0.06205 -0.01117
France 0.01975 0.2008 -0.02168 -0.0214 -0.01805 -0.02032 -0.00028
Germany 0.01415 0.03101 -0.08136 -0.07386 -0.05941 -0.07326 -0.0075
Hungary 0.04696 0.04052 -0.07032 -0.0531 -0.03804 -0.04984 -0.01722
Iceland 0.04117 0.09005 -0.06259 -0.05392 -0.04428 -0.05279 -0.00867
India 0.56138 0.10816 0.00549 0.00725 0.00506 0.0058 -0.00176
Ireland 0.16501 0.06958 -0.03008 -0.02443 -0.03142 -0.02394 -0.00565
Isle of Man 0.00885 0.06195 -0.05799 -0.0442 -0.03528 -0.04466 -0.01379
Israel 0.23209 0 -0.06315 -0.048 -0.03712 -0.04455 -0.01515
Italy 0.05808 0.03977 -0.07456 -0.06762 -0.05524 -0.06853 -0.00694
Japan 0.04869 0.04148 -0.06659 -0.04611 -0.03092 -0.04448 -0.02048
Kazakhstan 0.04267 0.21336 -0.01315 -0.0054 -0.0001 -0.00513 -0.00775
Mexico 0.09404 0.13644 -0.03411 -0.01966 -0.01217 -0.01758 -0.01445
Netherlands 0.06032 0.10269 -0.05643 -0.0539 -0.04592 -0.05264 -0.00253
Nicaragua 0.12052 0.45114 0.05098 0.0533 0.05278 0.05332 -0.00232
Nigeria 0.41863 0.18445 0.0144 0.0159 0.01485 0.01489 -0.0015
Norway 0.02321 0.06286 -0.06847 -0.06023 -0.04747 -0.05749 -0.00824
Peru 0.03488 0.14147 -0.04085 -0.02909 -0.02334 -0.02555 -0.01176
Spain 0.09172 0.23378 -0.0116 -0.0071 0.00214 -0.00672 -0.0045
Sri Lanka 0.19403 0.27032 0.01625 0.02531 0.02578 0.02476 -0.00906
Sweden 0.05049 0.06481 -0.06583 -0.04793 -0.04038 -0.0462 -0.0179
Switzerland 0.06763 0.0412 -0.07542 -0.07214 -0.06481 -0.06895 -0.00328
Uganda 0.28611 0.18889 0.01732 0.01764 0.01246 0.01555 -0.00032
Uruguay 0.04787 0.14096 -0.03916 -0.02318 -0.01523 -0.02209 -0.01598
USA 2 0.16125 0.1617 -0.02577 -0.01383 -0.0064 -0.01152 -0.01194
USA 3 0.26011 0.0707 -0.04069 -0.02818 -0.02105 -0.0261 -0.01251
USA 2 0.3263 0.18852 -0.11105 -0.06216 -0.05102 -0.05505 -0.04889
USA 3 0.38019 0.05805 -0.16022 -0.09638 -0.08313 -0.08908 -0.06384
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Table 9 Proportion estimates for lifetime abstainers and former drinkers, as well as Population-Attributable Fraction
(PAF) estimates for pancreatitis using a categorical model and continuous models (Gamma, Log-Normal, and Weibull)
for men
Proportions PAF estimates
Country Abstainers Former drinkers Categorical Gamma model Log-Normal model Weibull model PAFcategorical - PAFgamma
Argentina 0.02488 0.08209 0.22296 0.15927 0.43723 0.20014 0.06369
Australia 0.04 0.078 0.08654 0.08482 0.38073 0.10451 0.00172
Austria 0.07014 0.15774 0.28936 0.22295 0.35679 0.2301 0.06641
Belize 0.20958 0.28647 0.33325 0.24985 0.33703 0.27395 0.0834
Brazil 0.14516 0.2724 0.36261 0.29194 0.39178 0.32264 0.07067
Canada 0.05019 0.1359 0.21733 0.13226 0.33792 0.15511 0.08507
Costa Rica 0.07212 0.24279 0.12691 0.10615 0.29474 0.14666 0.02076
Czech Republic 0.02653 0.07235 0.45021 0.44383 0.59431 0.46265 0.00638
Denmark 0.00669 0.02899 0.21317 0.1266 0.36293 0.13557 0.08657
ECAS: Finland 0.06855 0 0.15448 0.09867 0.28828 0.1085 0.05581
ECAS: France 0.12632 0 0.27896 0.19496 0.44157 0.22458 0.084
ECAS: Germany 0.11828 0 0.11683 0.07036 0.27456 0.07978 0.04647
ECAS: Italy 0.107 0 0.14476 0.13578 0.42278 0.1422 0.00898
ECAS: Sweden 0.07803 0 0.14909 0.04825 0.19429 0.05417 0.10084
ECAS: UK 0.10422 0 0.52217 0.49318 0.58899 0.50824 0.02899
Finland 0.03181 0.05196 0.12555 0.07766 0.33705 0.0898 0.04789
France 0.01975 0.2008 0.24059 0.22953 0.39322 0.24816 0.01106
Germany 0.01415 0.03101 0.18565 0.16192 0.44023 0.17239 0.02373
Hungary 0.04696 0.04052 0.08571 0.0504 0.29853 0.07345 0.03531
Iceland 0.04117 0.09005 0.0527 0.04367 0.15151 0.04482 0.00903
India 0.56138 0.10816 0.40834 0.36381 0.36933 0.36204 0.04453
Ireland 0.16501 0.06958 0.58943 0.51065 0.5712 0.52348 0.07878
Isle of Man 0.00885 0.06195 0.41981 0.3877 0.57684 0.42486 0.03211
Israel 0.23209 0 0.15418 0.05803 0.26452 0.09695 0.09615
Italy 0.05808 0.03977 0.13931 0.18626 0.45169 0.18221 -0.04695
Japan 0.04869 0.04148 0.25401 0.2705 0.53622 0.35619 -0.01649
Kazakhstan 0.04267 0.21336 0.42465 0.27561 0.43974 0.30884 0.14904
Mexico 0.09404 0.13644 0.29837 0.18325 0.36482 0.23945 0.11512
Netherlands 0.06032 0.10269 0.13115 0.11909 0.29457 0.12463 0.01206
Nicaragua 0.12052 0.45114 0.35959 0.24862 0.30616 0.26612 0.11097
Nigeria 0.41863 0.18445 0.35308 0.37914 0.43234 0.39043 -0.02606
Norway 0.02321 0.06286 0.13943 0.06723 0.2652 0.07835 0.0722
Peru 0.03488 0.14147 0.17245 0.04226 0.05929 0.04328 0.13019
Spain 0.09172 0.23378 0.22602 0.19353 0.43043 0.20917 0.03249
Sri Lanka 0.19403 0.27032 0.36577 0.31928 0.36454 0.33162 0.04649
Sweden 0.05049 0.06481 0.03966 0.02675 0.08574 0.02787 0.01291
Switzerland 0.06763 0.0412 0.25281 0.12628 0.30113 0.14007 0.12653
Uganda 0.28611 0.18889 0.56306 0.5551 0.55585 0.55323 0.00796
Uruguay 0.04787 0.14096 0.39759 0.24 0.43627 0.2895 0.15759
USA 2 0.16125 0.1617 0.18083 0.11673 0.28693 0.15662 0.0641
USA 3 0.26011 0.0707 0.2473 0.11757 0.28915 0.15812 0.12973
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estimating this distribution using the relationship
between the mean and the standard deviation, and using
per capita consumption data, allows us to correct for the
biases that lead to undercoverage (for specifics on the
upshifting methods see [15]) and allows for the estima-
tion of the distribution of alcohol consumption in a
country as if it were measured by a survey with a much
higher coverage rate. Additionally, based on the relation-
ship between the mean and the standard deviation of the
alcohol consumption Gamma distribution, we can use
the mean alcohol consumption from sales and taxation
data to obtain the  and θ parameters for the alcohol
exposure distribution for those countries where no sur-
vey data exist. Due to great variations in the populations
surveyed, and in the sampling frame, response rate, and
coverage rate for each of the individual surveys within
the main survey groups of GENACIS, ECAS, and STEPS,
our observations that alcohol consumption can best be
modeled through a Gamma distribution and that the
mean is highly correlated with the standard deviation of
the alcohol consumption Gamma distribution indicate
that these results are applicable to a wide range of
countries and are valid for population surveys that use
different methodologies.
An interesting finding from our study was the identifi-
cation as outliers of some of the observations from
Nigeria. This could be due to multiple factors. The
number of observations from Nigeria upon which the
mean and the standard deviation of the alcohol con-
sumption Gamma distribution are based are fewer than
the number of observations from other countries. A
further factor is that the relationship between the mean
and standard deviation of the alcohol consumption
Gamma distribution for Nigeria may be different when
compared to other countries. Given that only some age
groups in Nigeria were identified by the regression diag-
nostics as outliers, it is very likely that these outliers
were due to the low number of individuals surveyed in
Nigeria. Future research will focus on modeling alcohol
consumption by global region (such as by using the
2005 Comparative Risk Assessment regions [44]) to see
if there are regional differences in the relationship
between the mean and the standard deviation of the
alcohol consumption Gamma distribution.
Table 10 Descriptive statistics of the alcohol surveys from 66 countries
Number of
estimates
Empirical
mean
Empirical standard
deviation
Gamma distribution
mean
Gamma distribution standard
deviation
Women 422 7.55 12.63 7.55 9.86
Men 429 18.29 25.60 18.29 22.01
Total 851 12.96 19.17 12.96 15.99
Figure 7 Regression analysis and scatter plot for the mean and
standard deviation of the alcohol consumption Gamma
distribution for women.
Figure 8 Regression analysis and scatter plot for the mean and
standard deviation of the alcohol consumption Gamma
distribution for men.
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Conclusion
When comparing the Log-Normal, Weibull, and Gamma
distributions to calculate average consumption of alco-
hol, the Gamma distribution and the Weibull distribu-
tion outperform the Log-Normal distribution in fitting
the empirical consumption distribution. Of these two
distributions, the Gamma distribution appears to be the
best choice for modeling as it has two parameters that
can easily be shifted to make the fit more compatible
with the per capita consumption data, thus making it
possible to estimate the exposure distribution of coun-
tries with only aggregate per capita consumption
reported, as long as prevalence of abstention is known
(see [15]). Thus, shifting the mean upwards is possible,
as the Gamma distribution can be described by two
parameters (mean and standard deviation), which
empirically can be reduced to one, as a large degree of
variance of the standard deviation of the alcohol con-
sumption Gamma distribution is explained by the mean
alcohol consumption. Accurate modeling of alcohol con-
sumption as an upshifted distribution will provide public
health decision-makers with accurate data to assess the
impact of alcohol consumption within and across coun-
tries and will aid in determining public health priorities
and where to allocate resources.
Additional material
Additional file 1: Web Appendix. This web appendix includes
parameter estimates using non-truncated data for women and men from
Log-Normal, Gamma, and Weibull models, proportion estimates for
lifetime abstainers and former drinkers, as well as Population Attributable
Fraction (PAF) estimates for breast cancer, diabetes, pancreatitis using a
categorical model and a continuous model. Count, proportion and
weighted global proportion estimates for women and men drinkers that
drink ≤ 96 g/day, > 96 g/day, ≤ 120 g/day, and > 120 g/day were also
included. Proportion estimates for the decomposition of alcohol
Population Attributable Fraction (PAF) are listed for breast cancer and
pancreatitis consisting of drinkers that drink ≤ 96 g/day and > 96 g/day,
≤ 120 g/day and > 120 g/day, ≤ 150 g/day and > 150 g/day, and ≤ 200
g/day and > 200 g/day using a continuous model (Gamma, Log-Normal,
and Weibull) for women and men.
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